Pulsed Field Ablation for Atrial Fibrillation

Created using ChatSlide

This presentation covers a landmark study in atrial fibrillation treatment, published in the New England Journal of Medicine and funded by Boston Scientific. The trial compares the effectiveness and safety of pulsed field ablation (PFA) versus traditional drug therapies in managing persistent AF. Conducted as a multicentre, randomised trial, it reveals PFA's superior efficacy and safety, positioning it as a potential first-line treatment. Results underscore the need for protocol modifications...